Cambridge, United Kingdom

Ribotargets Limited


USPTO Granted Patents = 6

Forward Citations = 36

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Jonathan Karn (6 out of 13 patents)

silverMedal Roger Kingdon Craig (2 out of 26 patents)

bronzeMedal Michael John Gait (2 out of 13 patents)

4.  Shaun Heaphy (2 out of 14 patents)

5.  Rodney Warren Zemmel (2 out of 2 patents)

6.  Peter Jonathan Gasking Butler (2 out of 2 patents)

7.  Alistair Simpson Irvine (2 out of 6 patents)

8.  Colin Dingwall (2 out of 4 patents)

9.  Catherine Denise Prescott (1 out of 3 patents)

10.  Alastair Iain Hamilton Murchie (1 out of 1 patent)

11.  David Justin Charles Knowles (1 out of 1 patent)

12.  Georg Friedrich Lentzen (1 out of 1 patent)


6 patents:

Company Overview
Ribotargets Limited is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics. With a focus on innovative approaches to RNA-based drug discovery, Ribotargets is dedicated to advancing precision medicine and improving patient outcomes in a wide range of disease areas. Their proprietary platform enables the identification of novel RNA targets and the design of small molecule therapeutics to modulate their activity. Collaborating with academic institutions, pharmaceutical companies, and other partners, Ribotargets is at the forefront of the rapidly evolving RNA therapeutics field.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#142 in Cambridge

#2,679 in United Kingdom

Cambridge, GB
Cambridge, United Kingdom
Forward Citations = 36

12 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ribotargets Limited. Retrieved from https://idiyas.com/company/ribotargets

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…